ISpecimen ROA 2020-2025 | ISPC
Current and historical return on assets (ROA) values for ISpecimen (ISPC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ISpecimen ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.01B | $0.01B | -112.82% |
| 2024-12-31 | $-0.01B | $0.01B | -106.67% |
| 2024-09-30 | $-0.01B | $0.01B | -69.23% |
| 2024-06-30 | $-0.01B | $0.01B | -70.18% |
| 2024-03-31 | $-0.01B | $0.01B | -69.84% |
| 2023-12-31 | $-0.01B | $0.02B | -55.56% |
| 2023-09-30 | $-0.01B | $0.02B | -44.44% |
| 2023-06-30 | $-0.01B | $0.02B | -43.01% |
| 2023-03-31 | $-0.01B | $0.02B | -38.10% |
| 2022-12-31 | $-0.01B | $0.03B | -34.48% |
| 2022-09-30 | $-0.01B | $0.03B | -31.50% |
| 2022-06-30 | $-0.01B | $0.03B | -30.77% |
| 2022-03-31 | $-0.01B | $0.03B | -26.17% |
| 2021-12-31 | $-0.01B | $0.04B | -48.65% |
| 2021-06-30 | $-0.01B | $0.02B | -120.00% |
| 2021-03-31 | $-0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.009B |
| iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.339B | 25.95 |
| CVS Health (CVS) | United States | $80.708B | 10.03 |
| Elevance Health (ELV) | United States | $77.846B | 10.05 |
| Cencora (COR) | United States | $57.726B | 20.08 |
| DiDi Global (DIDIY) | China | $28.851B | 30.65 |
| Labcorp Holdings (LH) | United States | $20.589B | 16.70 |
| Natera (NTRA) | United States | $20.264B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $12.835B | 0.00 |
| Solventum (SOLV) | United States | $12.635B | 13.38 |
| ICON (ICLR) | Ireland | $11.632B | 10.81 |
| Revvity (RVTY) | United States | $11.186B | 19.25 |
| Viatris (VTRS) | United States | $10.657B | 3.66 |
| Medpace Holdings (MEDP) | United States | $9.049B | 24.03 |
| Sonic Healthcare (SKHHY) | Australia | $8.827B | 0.00 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.446B | 37.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.988B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.610B | 14.91 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.902B | 37.73 |
| Alignment Healthcare (ALHC) | United States | $2.649B | 0.00 |
| Concentras Parent (CON) | United States | $2.522B | 14.58 |
| Organon (OGN) | United States | $2.503B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.296B | 88.43 |
| Progyny (PGNY) | United States | $1.973B | 43.43 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Premier (PINC) | United States | $1.730B | 13.13 |
| Ardent Health (ARDT) | United States | $1.718B | 7.32 |
| GoodRx Holdings (GDRX) | United States | $1.700B | 34.00 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.263B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.101B | 8.38 |
| CareDx (CDNA) | United States | $1.069B | 16.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.754B | 7.06 |
| InnovAge Holding (INNV) | United States | $0.590B | 0.00 |
| Nutex Health (NUTX) | United States | $0.578B | 8.75 |
| Embecta (EMBC) | United States | $0.570B | 3.84 |
| SBC Medicals (SBC) | United States | $0.543B | 0.00 |
| So-Young (SY) | China | $0.530B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Omada Health (OMDA) | $0.476B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.368B | 0.00 |
| Enhabit (EHAB) | United States | $0.346B | 28.50 |
| Performant Healthcare (PHLT) | United States | $0.318B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.074B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |